In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking
Crossref DOI link: https://doi.org/10.1007/s11655-020-3476-x
Published Online: 2020-07-06
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gao, Liang-qin
Xu, Jing
Chen, Shao-dong
Text and Data Mining valid from 2020-07-01
Version of Record valid from 2020-07-01
Article History
Accepted: 23 April 2020
First Online: 6 July 2020
Conflict of interest
: The authors declare that they have no conflict of interests.
Free to read: This content has been made available to all.